Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Metzger, B.E., et al., Hyperglycemia and adverse pregnancy outcomes. 2008. 358(19): p. 1991-2002.
  2. Fetita, L.-S., et al., Consequences of fetal exposure to maternal diabetes in offspring. 2006. 91(10): p. 3718-3724.
  3. Lowe, W.L., et al., Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. 2019. 42(3): p. 372-380.
  4. Metzger, B., J. Oats, and D. Coustan, Hod Results of the HAPO study: progress towards a new paradigm for detection & diagnosis of GDM. 5th International simposium on Diabetes and pregnancу. Italy (Sorrento), 2009. 640.
  5. Organization, W.H., Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. 1999, Geneva: World health organization.
  6. Diabetes, I.A.o. and P.S.G.C. Panel, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care, 2010. 33(3): p. 676-682.
  7. Дедов, И.И., В.И. Краснопольский, and Г.Т. Сухих, Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение». Сахарный диабет, 2012(4).
  8. Organization, W.H., Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013, World Health Organization.
  9. Federation, I.D., IDF Diabetes Atlas. 9th edition Brussels, Belgium: International Diabetes Federation; 2019.
  10. Catalano, P.M., et al., Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. American journal of obstetrics and gynecology, 1991. 165(6): p. 1667-1672.
  11. Catalano, P.M., et al., Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. American journal of obstetrics and gynecology, 1999. 180(4): p. 903-916.
  12. Barbour, L.A., et al., Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes care, 2007. 30(Supplement 2): p. S112-S119.
  13. Group, H.S.C.R., Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine, 2008. 358(19): p. 1991-2002.
  14. Crowther, C.A., et al., Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine, 2005. 352(24): p. 2477-2486.
  15. Landon, M.B., Obstetric management of pregnancies complicated by diabetes mellitus. Clinical obstetrics and gynecology, 2000. 43(1): p. 65-74.
  16. Riskin-Mashiah, S., et al., First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes care, 2009. 32(9): p. 1639-1643.
  17. ДЕРЯБИНА, Е.Г., Н.В. БАШМАКОВА, and Д.М.J.А.и.г. ЛАРЬКИН, Роль раннего скрининга гестационного сахарного диабета для оптимизации перинатальных исходов. 2013(9): p. 13-17.
  18. Allen, V.M., et al., Teratogenicity Associated With Pre-Existing and Gestational Diabete. 2007. 29(11): p. 927-934.
  19. Callec, R., et al., Type 2 diabetes in pregnancy: Rates of fetal malformations and level of preconception care. 2014. 34(7): p. 648-649.
  20. Peterson, C.M. and L. Jovanovic, Glucosylated proteins in normal and diabetic pregnancy, in Gestational Diabetes. 1988, Springer. p. 107-114.
  21. Wender-Ożegowska, E., et al., Threshold values of maternal blood glucose in early diabetic pregnancy-prediction of fetal malformations. 2005. 84(1): p. 17-25.
  22. Association, A.D., Professional Practice Committee: Standards of Medical Care in Diabetes—2020. 2020, Am Diabetes Assoc.
  23. Hessler, K.L. and K. Dunemn, Laboratory diagnosis of overt type 2 diabetes in the first trimester of pregnancy. Journal of the American Association of Nurse Practitioners, 2017. 29(9): p. 521-526.
  24. Wucher, H., et al., Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes. Diabetes & metabolism, 2011. 37(1): p. 47-51.
  25. Care, D., Standards of Medical Care in Diabetes 2019. Diabetes Care, 2019. 42: p. S81.
  26. Zhu, W.-w., et al., Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes care, 2013. 36(3): p. 586- 590.
  27. Corrado, F., et al., Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes & metabolism, 2012. 38(5): p. 458-461.
  28. Bozkurt, L., et al., Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria. The Journal of Clinical Endocrinology & Metabolism, 2015. 100(3): p. 1113-1120.
  29. Hanna, F.W., et al., Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c). Clinical Medicine, 2017. 17(2): p. 108.
  30. Benhalima, K., et al., Screening and management of gestational diabetes mellitus after bariatric surgery. Nutrients, 2018. 10(10): p. 1479.
  31. Kintiraki, E. and D.G. Goulis, Gestational diabetes mellitus: Multi-disciplinary treatment approaches. Metabolism, 2018. 86: p. 91-101.
  32. Скворцова, М.В., Приказ Министерства здравоохранения Российской Федерации от 1 ноября 2012 г. № 572н" Об утверждении Порядка оказания медицинской помощи по профилю" акушерство и гинекология (за исключением использования вспомогательных репродуктивных технологий)". Российская газета, 2013.
  33. Viana, L.V., J.L. Gross, and M.J. Azevedo, Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes care, 2014. 37(12): p. 3345- 3355.
  34. Peterson, C.M. and L. Jovanovic-Peterson, Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes, 1991. 40(Supplement 2): p. 172-174.
  35. Lain, K.Y. and P.M. Catalano, Metabolic changes in pregnancy. Clinical obstetrics and gynecology, 2007. 50(4): p. 938-948.
  36. Brown, J., et al., Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews, 2017(5).
  37. Gilbert, L., et al., How diet, physical activity and psychosocial well-being interact in women with gestational diabetes mellitus: an integrative review. BMC pregnancy and childbirth, 2019. 19(1): p. 60.
  38. Mitanchez, D., C. Ciangura, and S. Jacqueminet, How Can Maternal Lifestyle Interventions Modify the Effects of Gestational Diabetes in the Neonate and the Offspring? A Systematic Review of Meta-Analyses. Nutrients, 2020. 12(2): p. 353.
  39. Mendez-Figueroa, H., et al., Comparing daily versus less frequent blood glucose monitoring in patients with mild gestational diabetes. The Journal of Maternal-Fetal & Neonatal Medicine, 2013. 26(13): p. 1268-1272.
  40. Hawkins, J.S., et al., Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstetrics & Gynecology, 2009. 113(6): p. 1307-1312.
  41. de Veciana, M., et al., Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. New England Journal of Medicine, 1995. 333(19): p. 1237-1241.
  42. Mendez-Figueroa, H., et al., Gestational diabetes mellitus and frequency of blood glucose monitoring: a randomized controlled trial. Obstetrics & Gynecology, 2017. 130(1): p. 163- 170.
  43. Laird, M., Jason and M. McFarland, FACE, Kay F, Fasting blood glucose levels and initiation of insulin therapy in gestational diabetes. Endocrine Practice, 1996. 2(5): p. 330- 332.
  44. Hawkins, J.S., et al., Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. 2009. 113(6): p. 1307-1312.
  45. G Moses, R., E. M Luca, and S. Knights, Gestational diabetes mellitus. At what time should the postprandial glucose level be monitored? Australian and New Zealand journal of obstetrics and gynaecology, 1999. 39(4): p. 457-460.
  46. Sivan, E., et al., One or two hours postprandial glucose measurements: are they the same? American journal of obstetrics and gynecology, 2001. 185(3): p. 604-607.
  47. Weisz, B., et al., One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. Journal of perinatology, 2005. 25(4): p. 241-244.
  48. de Veciana, M., et al., Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. 1995. 333(19): p. 1237-1241.
  49. ГОСТ Р ИСО 15197-2015 Тест-системы для диагностики in vitro. Требования к системам мониторинга глюкозы в крови для самоконтроля при лечении сахарного диабета (электронный ресурс). [GOST R ISO 15197-2015 In vitro diagnostic test systems. Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. (In Russ.)] Доступно по: http://docs.cntd.ru/document/1200120137. .
  50. Rizzo, T., et al., Correlations between antepartum maternal metabolism and intelligence of offspring. New England Journal of Medicine, 1991. 325(13): p. 911-916.
  51. Gin, H., et al., Blood ketone monitoring: a comparison between gestational diabetes and non-diabetic pregnant women. Diabetes & metabolism, 2006. 32(6): p. 592-597.
  52. Popova, P.V., et al., Association of tribbles homologue 1 gene expression in human umbilical vein endothelial cells with duration of intrauterine exposure to hyperglycaemia. Genetics research, 2018. 100.
  53. Дедов, И.И., et al., Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение. Проблемы репродукции, 2018. 24(S6): p. 115-127.
  54. Brown, J., et al., Insulin for the treatment of women with gestational diabetes. 2017(11).
  55. Durnwald, C., Gestational diabetes mellitus: Glycemic control and maternal prognosis. UpToDate: https://www. uptodate. com/contents/gestational-diabetes-mellitus-glycemic- control-and-maternal-prognosis, 2018.
  56. McCulloch, D.K., General principles of insulin therapy in diabetes mellitus. UpToDate August, 2006. 3.
  57. Bonomo, M., et al., Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes & metabolism, 2004. 30(3): p. 237-243.
  58. Kjos, S.L., et al., A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes care, 2001. 24(11): p. 1904-1910.
  59. Адамян, Л., et al., Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол лечения). М, 2016.
  60. Сухих Г, Т., , Серов В.Н., Адамян Л.В., Филиппов О.С., Баев О.Р., Клименченко Н.И., Тетруашвили Н.К., Ходжаева З.С., Холин А.М., Преждевременные роды. Клинические рекомендации (протокол) Министерства здравоохранения РФ № 15- 4/10/2-9480 от 17.12.2013 г.
  61. Kautzky-Willer, A., et al., Gestationsdiabetes (GDM)(Update 2019). Wiener klinische Wochenschrift, 2019. 131(1): p. 91-102.
  62. Sacks, D.A., Etiology, detection, and management of fetal macrosomia in pregnancies complicated by diabetes mellitus. Clinical obstetrics and gynecology, 2007. 50(4): p. 980- 989.
  63. Schäfer-Graf, U. and A. Wöckel, Severe diabetic fetopathy due to undiagnosed gestational diabetes mellitus. Deutsche medizinische Wochenschrift (1946), 2006. 131(20): p. 1151- 1154.
  64. С.Н., Л., Особенности формирования диабетической фетопатии: диагностика и оптимизация акушерской тактики. Автореферат дисс. докт.мед.наук. Москва. 2019: p. С.41-44.
  65. Бурумкулова, Ф.Ф., et al., Диабетическая фетопатия и перинатальная патология при беременности, осложненной гестационным сахарным диабетом. Лечение и профилактика, 2013. 2: p. 125-132.
  66. NICE, NICE Guideline 3: Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. 2015.
  67. Boulvain, M., et al., Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. The Lancet, 2015. 385(9987): p. 2600-2605.
  68. Boulvain, M., et al., Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database of Systematic Reviews, 2016(5).
  69. Melamed, N., et al., Induction of labor before 40 weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus. American journal of obstetrics and gynecology, 2016. 214(3): p. 364. e1-364. e8.
  70. Feghali, M.N., et al., Timing of delivery and pregnancy outcomes in women with gestational diabetes. American journal of obstetrics and gynecology, 2016. 215(2): p. 243. e1-243. e7.
  71. Rosenstein, M.G., et al., The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. American journal of obstetrics and gynecology, 2012. 206(4): p. 309. e1-309. e7.
  72. Beta, J., et al., Maternal and neonatal complications of fetal macrosomia: systematic review and metaanalysis. Ultrasound in Obstetrics & Gynecology, 2019. 54(3): p. 308- 318.
  73. Баев, О., et al., Подготовка шейки матки к родам и родовозбуждение. Клинический протокол. Акушерство и гинекология, 2012(S4-2): p. 14-23.
  74. Адамян, Л.В. and В. СЕРОВ, ОКАЗАНИЕ МЕДИЦИНСКОЙ ПОМОЩИ ПРИ ОДНОПЛОДНЫХ РОДАХ В ЗАТЫЛОЧНОМ ПРЕДЛЕЖАНИИ (БЕЗ ОСЛОЖНЕНИЙ) И В ПОСЛЕРОДОВОМ ПЕРИОДЕ. Проблемы репродукции, 2015. 21(6S): p. 6-25.
  75. Адамян, Л., et al., Нейроаксиальные методы обезболивания родов. Клинические рекомендации. Анестезиология и реаниматология, 2018(5): p. 99-110.
  76. Barrett, H.L., J. Morris, and A. McELDUFF, Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2009. 49(2): p. 162-167.
  77. Waters, T.P., et al., Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes? American journal of obstetrics and gynecology, 2020. 222(1): p. 73. e1-73. e11.
  78. Billionnet, C., et al., Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia, 2017. 60(4): p. 636-644.
  79. Ayala, D.E. and R.C. Hermida, Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiology international, 2013. 30(1-2): p. 233-259.
  80. Sanchez-Lechuga, B., et al., Usefulness of blood pressure monitoring in patients with gestational diabetes mellitus. Endocrinología, Diabetes y Nutrición (English ed.), 2018. 65(7): p. 394-401.
  81. Рунихина, Н., М. Михайлусова, and Б. Барт, Хроническая артериальная гипертония и особенности ее течения в различные сроки беременности (по данным суточного мониторирования артериального давления). Кардиоваскулярная терапия и профилактика, 2006. 5(8).
  82. Spencer, L., et al., The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol. JBI database of systematic reviews and implementation reports, 2015. 13(1): p. 88-98.
  83. Blum, A.K., Insulin use in pregnancy: an update. Diabetes Spectrum, 2016. 29(2): p. 92- 97.
  84. Дементьева, Г.J.Г.п.и.н.Л.д.в.М.М.п.и.д.х.М.Р., Низкая масса тела при рождении. 2003. 6.
  85. Hadlock, F.P., et al., Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. 1985. 151(3): p. 333-337.
  86. Федерации, П.М.З.Р., О совершенствовании пренатальной диагностики в профилактике наследственных и врожденных заболеваний у детей. от 28 декабря 2000 года N 457.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*